Morning Briefing
Summaries of health policy coverage from major news organizations
Longer Looks: Interesting Reads You Might Have Missed
Mesfin Yana Dollar came to the U.S. for surgery. Now he works at the Mayo Clinic, assisting with some of the world鈥檚 most complex open-heart surgeries. (Penman, 12/3)
ER doctor Anne Flower, 36, started running as a way of coping with the demands of medical school when studying at Ohio University and became so good that, in 2020, she qualified for the U.S. Olympic marathon trials. Then the distances got further and she began breaking ultra-marathon records. (O'Neill, 12/4)
鈥淢asking鈥 is part of life, especially for those with autism or A.D.H.D. But hiding your true self comes with a cost. (Carson, 12/3)
The Trump administration鈥檚 cuts to biomedical funding could have big repercussions for people focused on a cure. (Fitzgerald, 12/1)
Recent data suggests the injury is rare 鈥 about two cases for every 100,000 people who checked into US emergency departments between 2001 and 2020, according to an August study 鈥 but podiatrists and orthopedists said they鈥檝e seen a significant uptick in the number of cases in the last few years, especially among people 40 and older. (Villano, 12/3)
As vultures vanished, dogs multiplied, and rabies spread. Humans are living with the consequences. (Johnson and Khandelwal, 11/29)
On Tuesday, Okava Pharmaceuticals, a biopharmaceutical company based in San Francisco, is set to announce that it has officially begun a pilot study of a GLP-1 drug for cats with obesity. The company is testing a novel approach: Instead of receiving weekly injections of the drugs, as has been common in human patients, the cats will get small, injectable implants, slightly larger than a microchip, that will slowly release the drug for as long as six months. (Anthes, 12/2)
